Back to top

Tonix Pharmaceuticals enrolls first patient in HORIZON study

Tonix Pharmaceuticals (TNXP) announced that the first patient has been enrolled in HORIZON, a potentially pivotal Phase 2 study evaluating TNX-102 ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: